[Sevoflurane inhalation anesthesia for short surgical interventions]

Area of Science:

• Anesthesiology
• Pharmacology

Background:

• Sevoflurane is a newer halogenated inhalation anesthetic agent.
• Its use as a sole anesthetic agent (mononarcosis) for various surgical procedures requires further investigation.

Purpose of the Study:

• To evaluate the safety and efficacy of sevoflurane as a sole anesthetic agent in patients undergoing short, non-cavitary general surgical and urological operations.

Main Methods:

• Thirty-three adult patients received sevoflurane via inhalation in a semi-open system.
• Anesthetic doses ranged from 0.2 vol% for induction to 2-3 vol% for maintenance.
• Monitoring included ECG, arterial pressure, pulse oximetry, capnography, and biochemical markers for organ function.

Main Results:

• Sevoflurane did not significantly suppress respiration, allowing for assisted ventilation if needed.
• Hemodynamic parameters remained stable, with no significant changes observed.
• Biochemical analyses showed no evidence of hepatic or renal dysfunction.

Conclusions:

• Sevoflurane is a safe and effective agent for mononarcosis in short non-cavitary surgical interventions.
• It minimizes the need for additional anesthetic or adjuvant medications.
• Further monitoring of heart rate is advised.